H

Hemant Surgical Industries Ltd
BSE:543916

Watchlist Manager
Hemant Surgical Industries Ltd
BSE:543916
Watchlist
Price: 269.9 INR 5.99%
Market Cap: ₹3.5B

Intrinsic Value

The intrinsic value for Hemant Surgical Industries Ltd (543916) under the Base Case is 161.28 INR. Compared with the current market price of 269.9 INR, the stock appears Overvalued by 40%.

Based on two methods:

DCF suggests overvaluation, while multiples suggest undervaluation.

HSIL Intrinsic Value
161.28 INR
Overvaluation 40%
Intrinsic Value
Price ₹269.9
H
Base Case Scenario
Get notified when the price drop
Track Buy Zone
20% below Intrinsic Value ₹129.03
Get notified when the price drops into your buy zone
Current Price ₹269.9
Intrinsic Value ₹161.28
Margin of Safety 20% ₹129.03
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Valuation History
Ask AI Assistant
What other research platforms think about HSIL?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is HSIL valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Hemant Surgical Industries Ltd.

Explain Valuation
Alternatives to HSIL

Fundamental Analysis

Financials

Revenue & Expenses Breakdown
Hemant Surgical Industries Ltd

Efficiency

Earnings Waterfall
Hemant Surgical Industries Ltd

Wall St
Price Targets

Dividends

Shareholder Yield

Competitive Landscape

What is the Intrinsic Value of one HSIL stock?

The intrinsic value for Hemant Surgical Industries Ltd (543916) under the Base Case is 161.28 INR.

Is HSIL stock undervalued or overvalued?

Compared with the current market price of 269.9 INR, the stock appears Overvalued by 40%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett